Purevax Rabies RSS Authorised This medicine is authorised for use in the European Union rabies recombinant canarypox virus (vCP65) Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Purevax Rabies Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Purevax Rabies : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 23/03/2011 Last updated: 17/10/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View español (ES) (81.97 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View čeština (CS) (93.99 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View dansk (DA) (83.34 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View français (FR) (82.44 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View íslenska (IS) (83.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View italiano (IT) (82.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View magyar (HU) (94.15 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Malti (MT) (95.95 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View norsk (NO) (82 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View polski (PL) (95.62 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View português (PT) (83.01 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View română (RO) (94.17 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Suomi (FI) (81.54 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View svenska (SV) (82.05 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Product information Purevax Rabies : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 23/03/2011 Last updated: 17/10/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View español (ES) (81.51 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View čeština (CS) (92.48 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View dansk (DA) (82.05 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View français (FR) (81.63 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View íslenska (IS) (81.52 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View italiano (IT) (81.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View magyar (HU) (92.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Malti (MT) (93.86 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View norsk (NO) (81.52 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View polski (PL) (93.22 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View português (PT) (82.53 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View română (RO) (91.73 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Suomi (FI) (81.11 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View svenska (SV) (81.47 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Purevax Rabies : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 23/03/2011 Last updated: 17/10/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View español (ES) (81.97 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View čeština (CS) (93.99 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View dansk (DA) (83.34 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View français (FR) (82.44 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View íslenska (IS) (83.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View italiano (IT) (82.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View magyar (HU) (94.15 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Malti (MT) (95.95 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View norsk (NO) (82 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View polski (PL) (95.62 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View português (PT) (83.01 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View română (RO) (94.17 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Suomi (FI) (81.54 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View svenska (SV) (82.05 KB - PDF) First published: 23/03/2011 Last updated: 17/10/2024 View Product details Name of medicine Purevax Rabies Active substance vCP65 virus International non-proprietary name (INN) or common name rabies recombinant canarypox virus (vCP65) Authorisation details EMA product number EMEA/V/C/002003 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Purevax Rabies : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 27/01/2012 Last updated: 17/10/2024 View Initial marketing authorisation documents Purevax Rabies : EPAR - Public assessment report English (EN) (81.49 KB - PDF)First published: 23/03/2011 Last updated: 17/10/2024 View CVMP summary of positive opinion for Purevax RabiesAdopted Reference Number: EMA/CVMP/144109/2010 English (EN) (53.84 KB - PDF)First published: 10/12/2010 Last updated: 10/12/2010 View News on Purevax Rabies Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 202324/03/2023 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 202116/04/2021 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 201820/04/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 February 201816/02/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 June 201716/06/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 12-14 July 201615/07/2016 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 6-8 October 201509/10/2015 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 7-9 July 201510/07/2015 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 8-10 July 201411/07/2014 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 March 201414/03/2014 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 July 201319/07/2013 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 February 201308/02/2013 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 201214/09/2012 Topics Medicines This page was last updated on 17/10/2024 Share this page